Fengjie Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment.
Journal: Nature immunology
Published: December 02, 2024
Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma.
Journal: The Journal of investigative dermatology
Published: October 19, 2023
ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma.
Journal: Frontiers in immunology
Published: August 25, 2023
Characteristics of Staphylococcus aureus Colonization in Cutaneous T-Cell Lymphoma.
Journal: The Journal of investigative dermatology
Published: March 16, 2023
Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment.
Journal: JCI insight
Published: August 25, 2022
High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma.
Journal: Acta dermato-venereologica
Published: December 02, 2021
PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.
Journal: Blood
Published: April 12, 2021
Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
Journal: The Journal of investigative dermatology
Published: February 03, 2020
Cutaneous flushing associated with Hodgkin lymphoma.
Journal: British journal of haematology
Published: March 25, 2019
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
Journal: The Journal of investigative dermatology
Published: March 09, 2018
Last Updated: 09/26/2026